<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Britannia Industries Limited

NSE: BRITANNIA · Lot size: 125

Britannia Industries Limited Open Interest & PCR Analysis

5,715.5Updated 21 Apr 2026, 01:26 pm IST
PCR
1.05
Neutral
Max Pain
5,600
Spot above by ₹116
Total CE OI
518K
Call writers
Total PE OI
545K
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-21

Frequently Asked Questions

What is Britannia Industries Limited PCR (Put-Call Ratio) today?
Britannia Industries Limited's current PCR is 1.05. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Britannia Industries Limited's PCR of 1.05 indicates neutral sentiment.
What is Britannia Industries Limited OI buildup type today?
Britannia Industries Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Britannia Industries Limited?
Britannia Industries Limited has total CE (call) OI of 517500 contracts and total PE (put) OI of 545000 contracts for the nearest expiry. The PCR is 1.05.
How is open interest analysis useful for Britannia Industries Limited trading?
OI analysis for Britannia Industries Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Britannia Industries Limited?
Britannia Industries Limited's max pain is ₹5,600 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.